Evidence map›Paper›PMID 35251652›Full record

ArticleClinical case reports2022

Familial essential thrombocythemia: 6 cases from a mono-institutional series.

Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Giorgia Vajana, Riccardo Tomasello, Cristina Rotolo, Giulia Camarda, Marta Mattana, Sergio Siragusa

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. The Contribution ofInternational journal of molecular sciences · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Vincenzo AccursoHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.ORCID https://orcid.org/0000-0002-0161-0957
Marco SantoroHematology Unit Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy.ORCID https://orcid.org/0000-0003-4390-8388
Salvatrice MancusoHematology Unit Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy.
Giorgia VajanaHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.
Riccardo TomaselloHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.
Cristina RotoloHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.ORCID https://orcid.org/0000-0001-7737-6290
Giulia CamardaHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.
Marta MattanaHematology Division University Hospital Policlinico "Paolo Giaccone" Palermo Italy.
Sergio SiragusaHematology Unit Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy.
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITDepartment of Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rarely essential thrombocythemia (ET) is diagnosed in more than one person within a family. Familial myeloproliferative neoplasms are underdiagnosed. In this report, we describe 6 couples of familial ET, evaluating the heterogeneity of the mutational state and the clinical presentation.

Indexed as

essential thrombocythemiafamilialmyeloproliferative neoplasms

Identifiers

PMID35251652
PMCPMC8886651
OpenAlexW4214553332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.